title: Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis.
authors.affiliation: Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi Hospital, Department of Specialistic, Diagnostic and Experimental Medicine, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
authors.forename: Nicola
authors.initials: N
authors.lastname: Polverelli
authors.forename: Lucia
authors.initials: L
authors.lastname: Catani
authors.forename: Daria
authors.initials: D
authors.lastname: Sollazzo
authors.forename: Nicola
authors.initials: N
authors.lastname: Vianelli
authors.forename: Francesca
authors.initials: F
authors.lastname: Palandri
mesh_terms: D000328:Adult; D017209:Apoptosis / Q000187:drug effects*; D001565:Benzoates / Q000009:adverse effects; D001792:Blood Platelets / Q000187:drug effects*; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood* / Q000188:drug therapy; D011720:Pyrazoles / Q000009:adverse effects; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects; D013926:Thrombopoietin / Q000009:adverse effects; D013997:Time Factors
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag